The research of the last two decades in the field of SRS-A and peptido
leukotriene (pLT) antagonists has provided information for the design
of potent pLT antagonists, which share some or all of the following st
ructural elements: (1) a lipophilic anchor, which fits into the lipoph
ilic pocket of the LTD4 receptor; (2) a central lipophilic unit mimick
ing the tetraene system of LTD4; (3) one or two acidic groups, as mimi
cs of the cysteinyl-glycine unit and/or the carboxylic group in the ei
cosanoid backbone of LTD4; (4) spacers connecting these elements. Pote
nt pLT antagonists lacking a second polar binding group compensate by
stronger interaction in other regions of the receptor. Identification
of pLT antagonists is based on lead optimisation, preparation of pLT a
nalogs and on the knowledge of the pLT receptor.